Gaetano Caramori Selected Research

Glucocorticoids

1/2022	Corticosteroid resistance in asthma: Cellular and molecular mechanisms.
10/2021	[Risk of diabetes mellitus during regular long-term inhaled glucocorticoid treatment in COPD patients: narrative review of the literature.]
1/2019	Long-term use of inhaled glucocorticoids in patients with stable chronic obstructive pulmonary disease and risk of bone fractures: a narrative review of the literature.
12/2017	Fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease.
4/2017	[Risk of pneumonia during long term regular treatment of stable COPD with inhaled glucocorticoids: a systematic review.]
1/2016	Nasal inflammation and its response to local glucocorticoid regular treatment in patients with persistent non-allergic rhinitis: a pilot study.
11/2015	Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD.
1/2014	Profile of fluticasone furoate/vilanterol dry powder inhaler combination therapy as a potential treatment for COPD.
11/2013	Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor κB and c-Jun N-terminal kinase activation.
6/2012	Strategies for improving the efficacy and therapeutic ratio of glucocorticoids.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gaetano Caramori Research Topics

Disease

67	Chronic Obstructive Pulmonary Disease (COPD) 12/2023 - 01/2003
40	Asthma (Bronchial Asthma) 01/2022 - 06/2002
28	Inflammation (Inflammations) 01/2023 - 09/2002
7	Infections 01/2021 - 02/2008
6	Airway Remodeling 12/2022 - 01/2004
4	Emphysema 11/2023 - 01/2012
4	COVID-19 03/2023 - 01/2020
4	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2019 - 01/2006
4	Pneumonia (Pneumonitis) 04/2017 - 05/2005
3	Neoplasms (Cancer) 02/2024 - 03/2019
3	Lung Neoplasms (Lung Cancer) 12/2023 - 06/2011
3	Genetic Predisposition to Disease (Genetic Predisposition) 03/2023 - 07/2011
2	Respiratory Insufficiency (Respiratory Failure) 03/2023 - 01/2017
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 03/2023 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 11/2020
2	Leukemia 01/2021 - 01/2004
2	Virus Diseases (Viral Diseases) 01/2021 - 01/2006
2	Lung Injury 07/2020 - 01/2019
2	Pulmonary Emphysema 01/2018 - 10/2006
2	Necrosis 01/2015 - 12/2005
2	Familial Primary Pulmonary Hypertension 08/2014 - 01/2013
2	Eosinophilia 03/2012 - 09/2002
2	Cystic Fibrosis (Mucoviscidosis) 03/2006 - 05/2005
1	Adenocarcinoma of Lung 02/2024
1	Adenocarcinoma 02/2024
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023
1	Lung Diseases (Lung Disease) 11/2021
1	Diabetes Mellitus 10/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Lymphoma (Lymphomas) 01/2021

Drug/Important Bio-Agent (IBA)

18	GlucocorticoidsIBA 01/2022 - 01/2003
16	Proteins (Proteins, Gene)FDA Link 12/2022 - 08/2002
15	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 06/2002
12	SmokeIBA 11/2023 - 06/2006
11	Biomarkers (Surrogate Marker)IBA 12/2023 - 10/2006
11	CytokinesIBA 01/2023 - 08/2004
10	Messenger RNA (mRNA)IBA 11/2023 - 05/2005
9	Transcription Factors (Transcription Factor)IBA 01/2019 - 08/2004
7	ChemokinesIBA 06/2022 - 08/2004
7	Bronchodilator Agents (Bronchodilators)IBA 10/2021 - 01/2003
7	Antiviral Agents (Antivirals)IBA 01/2021 - 12/2012
7	SteroidsIBA 02/2014 - 08/2002
5	Phosphotransferases (Kinase)IBA 06/2022 - 01/2004
5	AntioxidantsIBA 06/2022 - 10/2006
4	InterferonsIBA 06/2020 - 12/2012
4	p38 Mitogen-Activated Protein KinasesIBA 01/2018 - 01/2004
4	EnzymesIBA 01/2018 - 08/2004
4	NF-kappa B (NF-kB)IBA 01/2016 - 03/2006
4	Interleukin-8 (Interleukin 8)IBA 01/2015 - 05/2005
3	RNA-Binding Proteins (RNA-Binding Protein)IBA 12/2023 - 01/2018
3	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 08/2021 - 05/2014
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021 - 01/2017
3	DNA (Deoxyribonucleic Acid)IBA 06/2020 - 06/2011
3	Theophylline (Theon)FDA LinkGeneric 05/2014 - 06/2002
3	Dexamethasone (Maxidex)FDA LinkGeneric 11/2013 - 12/2005
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2011 - 08/2004
2	Interleukin-33IBA 02/2024 - 08/2014
2	Monoclonal AntibodiesIBA 11/2023 - 09/2008
2	Azithromycin (Zithromax)FDA LinkGeneric 01/2023 - 01/2020
2	Peptide Hydrolases (Proteases)FDA Link 12/2022 - 10/2006
2	SenotherapeuticsIBA 06/2022 - 12/2020
2	Oxidants (Oxidizing Agents)IBA 06/2022 - 06/2011
2	Muscarinic AntagonistsIBA 10/2021 - 12/2020
2	Chemokine ReceptorsIBA 01/2021 - 09/2004
2	Immunoglobulin E (IgE)IBA 01/2021 - 03/2012
2	AntigensIBA 10/2020 - 01/2018
2	MucinsIBA 01/2020 - 02/2016
2	InflammasomesIBA 05/2019 - 06/2014
2	Interleukin-27 (Interleukin 27)IBA 01/2019 - 06/2014
2	AutoantibodiesIBA 01/2018 - 10/2011
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2018 - 01/2015
2	vilanterolIBA 12/2017 - 01/2014
2	fluticasone furoate FDA Link 12/2017 - 01/2014
2	InterleukinsIBA 01/2016 - 08/2014
2	PeriostinIBA 01/2016 - 06/2012
2	LipopolysaccharidesIBA 01/2015 - 06/2013
2	Interleukin-6 (Interleukin 6)IBA 08/2014 - 06/2014
2	AllergensIBA 03/2012 - 09/2002
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 04/2010 - 02/2006
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 04/2009 - 06/2006
2	Xanthine OxidaseIBA 10/2008 - 11/2005
2	Anti-Asthmatic Agents (Antiasthmatic Drugs)IBA 02/2008 - 09/2004
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2006 - 09/2002
1	Mast Cell StabilizersIBA 11/2023
1	Imiquimod (Aldara)FDA LinkGeneric 11/2023
1	Toll-Like Receptor 7IBA 11/2023
1	Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric 11/2023
1	ProteomeIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Chymases (Chymase)IBA 12/2022
1	protease SIBA 12/2022
1	Secretory Immunoglobulin A (SIgA)IBA 08/2022
1	MicroRNAs (MicroRNA)IBA 11/2021
1	HMGB1 Protein (HMG1)IBA 01/2021
1	Antimicrobial PeptidesIBA 01/2021
1	HLA-C Antigens (HLA-C)IBA 01/2021

Therapy/Procedure

35	Therapeutics 01/2023 - 06/2002
2	Aftercare (After-Treatment) 02/2008 - 01/2003
1	Mechanical Ventilators (Ventilator) 03/2023
1	Transplantation 01/2021